Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest [Phase 3]
Phase 3 trial update evaluating two doses of intravenous nesiritide (NATRECOR) in patients with worsening congestive heart failure and dyspn…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failure [Phase 3]
Phase 3 safety study comparing Natrecor (Nesiritide) to Dobutamine for worsening congestive heart failure has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Paracor Ventricular Support System (PVSS) for Patients With Heart Failure [Phase 1]
Phase 1 trial of the Paracor Ventricular Support System for heart failure has been terminated; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: The Effect of Hyperglycemia on LV Function and Exercise Capacity in Diabetics With and Without Heart Failure. [Phase 2]
Phase 2 clinical trial evaluating how hyperglycemia affects left ventricular function and exercise capacity in people with Type 2 diabetes, …
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure [Phase 2]
Phase 2 study comparing once-daily versus twice-daily dosing of valsartan in patients with stable chronic heart failure.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-06-08FDA Approved: RAMIPRIL — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved Rising Pharma Holdings' original application for ramipril (generic ramipril), enabling the company to market a ramipril pro…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Left Atrial Distensibility to Predict Left Ventricular Filling Pressure and Prognosis in Patients With Severe Mitral Regurgitation
A completed clinical study evaluates whether left atrial distensibility can predict left ventricular filling pressures and prognosis in pati…
-
CLINICAL_TRIALS trial_result · 2011-06-03Clinical Trial Update: Handled Echocardiography and Chronic Heart Failure [NA]
The clinical trial NCT01365325 evaluating echocardiography handling in chronic heart failure has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: MADIT-CRT: Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy [NA]
MADIT-CRT trial evaluate automatic implantable cardioverter defibrillator with cardiac resynchronization therapy; completed with results pos…
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: Home-based Disease Management Program to Improve Clinical Outcomes in Patients With Heart Failure [Phase 3]
A Phase 3 trial evaluating a home-based disease management program for heart failure has completed. The snippet notes completion but does no…
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: Trial in Cardiac Resynchronization Therapy (CRT): Right Ventricular Apex Versus High Posterior Septum [Phase 2]
Phase 2 clinical trial update comparing right ventricular apex versus high posterior septum pacing in cardiac resynchronization therapy for …
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure [Phase 2]
Phase 2 study evaluating the safety and efficacy of follow-up serial infusions of nesiritide (Natrecor) for heart failure has completed.
-
FDA approval · 2011-05-19FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the Spironolactone and Hydrochlorothiazide combination submitted by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA [Phase 2]
This is a Phase 2 clinical study evaluating Nesiritide in patients undergoing CABG surgery that has completed. The trial status is finished.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Evaluation of Combined Action Between Natrecor and Furosemide on Kidney and Neurohormone Responses in Chronic Heart Failure: A Phase-IV study704.351 / DSS [Phase 4]
A Phase 4 study evaluating the combined action of natrecor (nesiritide) and furosemide on kidney and neurohormonal responses in chronic hear…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Enhanced External Counterpulsation
A clinical trial evaluating Enhanced External Counterpulsation, sponsored by Far Eastern Memorial Hospital, has completed and involved patie…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Short Term Hemodynamic Effects of Controlled Slow Breathing With Biofeedback in Patients With Heart Failure [NA]
A completed clinical trial evaluating the short-term hemodynamic effects of controlled slow breathing with biofeedback in patients with hear…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: A Cluster Randomized Trial to Assess the Impact of Opinion Leader Endorsed Evidence Summaries on Improving Quality of Prescribing for Patients With Chronic Cardiovascular Disease [NA]
This update reports the completion of a cluster randomized trial evaluating whether opinion leader–endorsed evidence summaries can improve q…
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: Effectiveness of the Treatment With Continuous Positive Airway Pressure(CPAP)in Stable Heart Failure With Ejection Fraction More Than 45% and Sleep Disordered Breathing [NA]
A completed clinical trial assessing the effectiveness of continuous positive airway pressure (CPAP) therapy in stable heart failure patient…
-
CLINICAL_TRIALS research · 2011-04-28Clinical Trial Update: Comparative Study of Cardiopulmonary Exercise Test Land Versus Water [Phase 2, Phase 3]
This is a Phase 2/3 clinical trial evaluating cardiopulmonary exercise testing on land versus in water in patients with heart failure; the t…
-
CLINICAL_TRIALS trial_result · 2011-04-08Clinical Trial Update: An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial [Phase 3]
An update on the RED-HF Phase 3 trial of darbepoetin alfa in heart failure shows an exploratory sub-study was conducted, and the trial has b…
-
CLINICAL_TRIALS trial_result · 2011-04-07Clinical Trial Update: Effect of Oxygen on Core Temperature [NA]
A completed trial investigating the effect of supplemental oxygen on core body temperature in patients with heart failure exhibiting Cheyne-…
-
CLINICAL_TRIALS trial_result · 2011-04-05Clinical Trial Update: Biventricular Pacing In Patients With Left Ventricular Dysfunction After Cardiovascular Surgery [Phase 3]
Phase 3 clinical trial update on using biventricular pacing for patients with left ventricular dysfunction after cardiovascular surgery; the…
-
FDA approval · 2011-04-01FDA Approved: CARVEDILOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for carvedilol from Teva Pharmaceuticals USA, Inc., authorizing the marketing of the generic car…
-
FDA approval · 2011-03-30FDA Approved: FOSINOPRIL SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for fosinopril sodium from Aurobindo Pharma Limited, making it a generic product.